Buy Mirtazapine (Remeron) Cas 85650-52-8

Mirtazapine, sold under the brand name Remeron among others, is an atypical tetracyclic antidepressant, and as such is used primarily to treat depression.^[10][11] Its effects may take up to four weeks but can also manifest as early as one to two weeks.^[11][12] It is often used in cases of depression complicated by anxiety or insomnia.^[10][13] The effectiveness of mirtazapine is comparable to other commonly prescribed antidepressants.^[14] It is taken by mouth.^[11]

Common side effects include sleepiness, dizziness, increased appetite, and weight gain.^[11] Serious side effects may include mania, low white blood cell count, and increased suicide among children.^[11] Withdrawal symptoms may occur when stopping.^[15] It is not recommended together with a monoamine oxidase inhibitor,^[11] although evidence supporting the danger of this combination has been challenged.^[16] It is unclear if use during pregnancy is safe.^[11] How it works is not clear, but it may involve blocking certain adrenergic and serotonin receptors.^[10][11] Chemically, it is a tetracyclic antidepressant,^[11] and is closely related to mianserin. It also has strong antihistaminergic effects.^[10][11]

Mirtazapine came into medical use in the United States in 1996.^[11] The patent expired in 2004, and generic versions are available.^[11][17] In 2023, it was the 99th most commonly prescribed medication in the United States, with more than 6 million prescriptions.^[18][19]

Mirtazapine is approved by the United States Food and Drug Administration for the treatment of major depressive disorder in adults.^[20]

Mirtazapine is primarily used for major depressive disorder and other mood disorders.^[21][22] Onset of action appears faster than some selective serotonin reuptake inhibitors and similar to tricyclic antidepressants.^[12][23]

In 2010, the National Institute for Health and Care Excellence recommended generic selective serotonin reuptake inhibitors as first-line choices, as they are “equally effective as other antidepressants and have a favourable risk–benefit ratio.”^[24] For mirtazapine, it found “no difference between mirtazapine and other antidepressants on any efficacy measure, although in terms of achieving remission mirtazapine appears to have a statistical though not clinical advantage. In addition, mirtazapine has a statistical advantage over selective serotonin reuptake inhibitors in terms of reducing symptoms of depression, but the difference is not clinically significant. However, there is strong evidence that patients taking mirtazapine are less likely to leave treatment early because of side effects, although this is not the case for patients reporting side effects or leaving treatment early for any reason.”^[25]

A 2011 Cochrane review comparing mirtazapine to other antidepressants found that while it appeared to have a faster onset in people for whom it worked (measured at two weeks), its efficacy was about the same as other antidepressants after six weeks’ use.^[12]

A 2012 review focused on antidepressants and sleep found that mirtazapine reduced the time it took to fall asleep and improved the quality of sleep in many people with sleep disorders caused by depression, but that it could also disturb sleep in many people, especially at higher doses, causing restless leg syndrome in 8 to 28% of people and in rare cases causes REM sleep behavior disorder.^[26] This seemingly paradoxical dose–response curve of mirtazapine with respect to somnolence is owed to the exceptionally high affinity of the drug for the histamine H₁, 5-HT_2A, and 5-HT_2C receptors; exhibiting near exclusive occupation of these receptors at doses ≤15 mg. However, at higher doses, inverse agonism and constitutive activation of the α_2A–, α_2B–, and α_2C-adrenergic receptors begins to offset activity at H₁ receptors leading to decreased somnolence and even a subjective sensation of “activation” in treated patients.^[27]

A 2018 analysis of 21 antidepressants found them to be fairly similar overall.^[28] It found tentative evidence for mirtazapine being in the more effective group and middle in tolerability.^[28]

After one week of usage, mirtazapine was found to have an earlier onset of action compared to selective serotonin reuptake inhibitors.^[23][29]